It seems that companies whose products and services are not finding takers in the current market are pivoting at the drop of a hat to become Bitcoin (BTCUSD) treasury companies. While the most prominent among them has been the Michael Saylor-led MicroStrategy (MSTR), recently, two biotech companies have also “rebranded” their business operations to load up on the world’s largest cryptocurrency.
Read More: Top Cannabis Stock Makes Bold Move into Bitcoin. Buy?
Comments are closed, but trackbacks and pingbacks are open.